Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study
Research output: Contribution to journal › Journal article › Research › peer-review
Abacavir-lamivudine and tenofovir DF-emtricitabine fixed-dose combinations are commonly used as first-line antiretroviral therapies. However, few studies have comprehensively compared their relative safety profiles.
Original language | English |
---|---|
Journal | Clinical Infectious Diseases |
Volume | 51 |
Issue number | 8 |
Pages (from-to) | 963-72 |
Number of pages | 10 |
ISSN | 1058-4838 |
DOIs | |
Publication status | Published - 15 Oct 2010 |
ID: 34052069